Review
Published on 11 Nov 2022
Artificial intelligence for precision medicine in autoimmune liver disease
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.966329
- 6,509 views
- 9 citations
Type at least 3 characters
2,749 articles
Articles
Original Research
Published on 10 Nov 2022
A subtractive proteomics approach for the identification of immunodominant Acinetobacter baumannii vaccine candidate proteins
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1001633
- 3,270 views
- 2 citations
Original Research
Published on 10 Nov 2022
TriTECM: A tetrafunctional T-cell engaging antibody with built-in risk mitigation of cytokine release syndrome
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1051875
- 7,868 views
- 5 citations
Original Research
Published on 10 Nov 2022
1270 nm near-infrared light as a novel vaccine adjuvant acts on mitochondrial photoreception in intradermal vaccines
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1028733
- 2,717 views
- 2 citations
Brief Research Report
Published on 09 Nov 2022
SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1017232
- 2,515 views
- 1 citation
Original Research
Published on 09 Nov 2022
A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1011484
- 3,322 views
- 6 citations
Original Research
Published on 09 Nov 2022
A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.983621
- 4,939 views
- 6 citations
Original Research
Published on 09 Nov 2022
Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1023255
- 3,355 views
- 5 citations
Original Research
Published on 09 Nov 2022
Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.933594
- 6,594 views
- 9 citations
Original Research
Published on 08 Nov 2022
Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.948335
- 5,325 views
- 5 citations
Original Research
Published on 08 Nov 2022
RIG-I and TLR-7/8 agonists as combination adjuvant shapes unique antibody and cellular vaccine responses to seasonal influenza vaccine
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.974016
- 5,508 views
- 9 citations
Brief Research Report
Published on 08 Nov 2022
A single birth dose of Hepatitis B vaccine induces polyfunctional CD4+ T helper cells
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1043375
- 2,760 views
Original Research
Published on 08 Nov 2022
Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1023558
- 2,632 views
- 9 citations
Original Research
Published on 08 Nov 2022
Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3–9-month intervals following two-dose inactivated vaccine (CoronaVac)
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1017590
- 2,483 views
- 7 citations
Original Research
Published on 07 Nov 2022
Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1030238
- 2,063 views
- 5 citations
Original Research
Published on 03 Nov 2022
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1029269
- 9,014 views
- 18 citations